Detalhe da pesquisa
1.
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Circulation;
141(10): 843-862, 2020 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31992065